These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15710950)

  • 1. Standards of proof, standards of practice, and proof of standards: a tale of two trials.
    Browman GP
    J Clin Oncol; 2005 Apr; 23(12):2583-5. PubMed ID: 15710950
    [No Abstract]   [Full Text] [Related]  

  • 2. The target hemoglobin in patients with chronic kidney disease.
    Singh AK
    Nephrol News Issues; 2006 Dec; 20(13):29-30. PubMed ID: 17168056
    [No Abstract]   [Full Text] [Related]  

  • 3. Taking critical appraisal to extremes. The need for balance in the evaluation of evidence.
    Woolf SH
    J Fam Pract; 2000 Dec; 49(12):1081-5. PubMed ID: 11132056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
    Scales CD; Norris RD; Keitz SA; Peterson BL; Preminger GM; Vieweg J; Dahm P
    J Urol; 2007 Mar; 177(3):1090-4; discussion 1094-5. PubMed ID: 17296417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is the function of "practice guidelines"?].
    Revuz J
    Ann Dermatol Venereol; 1999 Mar; 126(3):207-9. PubMed ID: 10394431
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing anemia. What do we do now? Views from Canada.
    Mendelssohn DC; Muirhead N; Manns BJ
    Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correction of anemia in renal insufficiency: what target?].
    Drüeke TB
    Nephrol Ther; 2008 Oct; 4 Spec No 2():1-8. PubMed ID: 19000892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Change of hemoglobin level: causes and consequences. Renal anemia].
    Ryckelynck JP
    Nephrol Ther; 2008 Oct; 4 Spec No 2():9-16. PubMed ID: 19000893
    [No Abstract]   [Full Text] [Related]  

  • 10. From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy.
    Coyne DW
    Semin Dial; 2008; 21(3):212-6. PubMed ID: 18363603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of erythropoietin].
    Godin M
    Soins; 2004 Sep; (688 Suppl):5. PubMed ID: 15526820
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines.
    Djulbegovic B
    Best Pract Res Clin Haematol; 2005; 18(3):455-66. PubMed ID: 15792920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based dentistry. How to use it.
    Seidel-Bittke D
    Dent Today; 2003 Mar; 22(3):50-5. PubMed ID: 12705010
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evidence-based medicine, or evidence research in everyday practice].
    Yernault JC
    Rev Med Brux; 1998 Jun; 19(3):115-7. PubMed ID: 9697392
    [No Abstract]   [Full Text] [Related]  

  • 15. What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials?
    Clark WF; Sontrop JM
    Clin J Am Soc Nephrol; 2008 May; 3(3):895-8. PubMed ID: 18287258
    [No Abstract]   [Full Text] [Related]  

  • 16. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [GRADE guidelines: 2. Framing the question and deciding on important outcomes].
    Langer G; Meerpohl JJ; Perleth M; Gartlehner G; Kaminski-Hartenthaler A; Schünemann H
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):369-76. PubMed ID: 22818161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment.
    Greenfield S; Kravitz R; Duan N; Kaplan SH
    Am J Med; 2007 Apr; 120(4 Suppl 1):S3-9. PubMed ID: 17403380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines.
    Mahon J
    CMAJ; 2000 Apr; 162(7):1002-4. PubMed ID: 10763399
    [No Abstract]   [Full Text] [Related]  

  • 20. What is evidence?
    Drake RE; Latimer EA; Leff HS; McHugo GJ; Burns BJ
    Child Adolesc Psychiatr Clin N Am; 2004 Oct; 13(4):717-28. PubMed ID: 15380783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.